Skip to main content
Caplight Logo









Homage

Homage

Private
SingaporeHealthcare & Life Scienceshttps://www.homage.sg/

Last Round

Series C

Sep 3, 2021

Est. Valuation

$100M

Total Funding Raised

$35.35M

Company Overview

Homage is a health-tech company that provides a technology-driven care and health services platform connecting care professionals with seniors and adults for on-demand services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

home careeldercarecaregiver marketplacetelehealthnursing servicesworkforce managementcare platformgig economy healthcareB2B healthcare softwarehome health aidedisability supportcare coordinationhealthtechSaaScaregiving app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Homage Comparables

Compare Homage with similar companies based on industry and business-model similarity.

Homage comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Five Good Friends
81%
Alliance Healthcare Group Ltd
79%
Carer Pte. Ltd.
78%

Homage Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 3, 2021
StrategicSep 14, 2020
Series BJan 13, 2020
Series AJul 3, 2018
SeedMar 15, 2017

Key People

Founding team and executive leadership

Gillian Tee

Founder and Chief Executive Officer

Founding Team

Homage Investors

Notable investors and investment history

Homage investors
InvestorRounds
SeedPlusSeries C, Series A, Seed
Sheares Healthcare GroupSeries C
Golden Gate VenturesSeed, Series A
500 GlobalSeed
KDV CapitalSeries B
HealthXCapitalSeries C, Series B, Series A
DG Daiwa VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 46% MoM, reaching 61.5K.

  • Sep 14, 2020

    Infocom led the strategic round.

Homage Filings

Explore SEC and related filing metadata, where available.

Homage filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Homage's valuation, stock price, and market status.

Is Homage a public or private company?

Homage is a private company.

What is the current stock price of Homage?

Homage is a private company with no public stock price. No recent secondary market data is available.

How much is Homage worth (valuation)?

Valuation information for Homage is not publicly available.

Can I buy Homage stock?

Homage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Homage's last funding round?

Homage's most recent funding round was Series C on September 3, 2021.

Who are the main investors in Homage?

Key investors in Homage include SeedPlus, Sheares Healthcare Group, Golden Gate Ventures, HealthXCapital, East Ventures.

Will Homage IPO soon?

No public IPO plans have been announced for Homage.

How can I track Homage secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Homage's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range315
Year Founded2016
Last FundingSep 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?